BINA DAILY · 2026-09-14
Today: AI policy and product news, plus the latest in health and medicine.
|
BINA DAILY · 2026-09-14
|
|
AI BRIEF
AI's Accountability Moment: Governance, Climate, and Record Billions
UNESCO launches ethics tools, the EU starts fining, UK health AI gets scrutiny, fossil fuel AI's hidden climate cost, and Mistral raises €3B.
IN TODAY'S BRIEF
- UNESCO Opens the First Global AI Ethics Forum in Riyadh
- UK Commission: Healthcare AI Needs Risk-Based Rules, Not Just Optimism
- The Real Climate Cost of AI Is in the Oil Field, Not the Data Center
- Mistral Raises €3 Billion as Europe's AI Funding Wave Peaks
- BIS Warns AI Is Now a Financial Stability Variable
- EU AI Act Enforcement Begins: The First Fines Are Coming
Read the full AI brief →
|
|
|
HEALTH ROUNDUP
Pain Relief Reimagined, HIV Prevention Expanded, and Europe's Respiratory Alert
A non-opioid analgesic advances; WHO broadens lenacapavir HIV guidance; baxdrostat impresses in resistant hypertension; mpox update.
IN TODAY'S BRIEF
- Suzetrigine's Chronic Pain Milestone Challenges the Opioid Default
- WHO Extends Lenacapavir HIV Prevention Guidance to All High-Risk Adults Worldwide
- Senolytic Therapy Cuts Hospitalisations in Older Adults in Phase 2 Frailty Trial
- Europe and Cyprus Move Early on the 2026–27 Respiratory Season
- Baxdrostat Delivers Meaningful Blood-Pressure Reduction in Treatment-Resistant Hypertension
- EU Approves CAR-T Therapy Obe-Cel for Young Adults With Relapsed Leukaemia
- WHO Classifies Mpox Clade Ib as Endemic in Three East African Countries; European Cases Tick Upward
Read the full health roundup →
|
